Aspect Biosystems
A Biomaterials Co-op at Aspect Biosystems supports R&D in developing bioprinted tissues for therapeutic applications. The role involves working with engineers and scientists to create and test biomaterials for medical use.
Headquarters
Vancouver, British Columbia, Canada
Company Size
51-200 employees
Founded
2013
Aspect Biosystems is a biotechnology company pioneering bioprinted tissue therapeutics. Its full‑stack platform combines proprietary AI‑powered bioprinting, computational design tools, therapeutic cells, and advanced biomaterials to manufacture allogeneic implantable tissues. The company is developing a targeted pipeline focused on metabolic and endocrine diseases and partners with pharma and biotech to translate therapies to the clinic. A multidisciplinary team of scientists, engineers, and entrepreneurs drives its regenerative‑medicine efforts.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Aspect Biosystems.
94% below the average for this role
Research Trainee 3D Bioprinting and Next Generation Disease Models - all genders (limited for 24 months)
sanofi us
Technical Research Co-op
Teknor Apex Company
Research Associate – Cell Biology & Bioengineering
Eurofins
Sr. Scientist II, Biomaterials Research
AbbVie
Visiting Scholar Program (On-Site)
Terasaki Institute for Biomedical Innovation
Chemistry / Chemical Engineering Drexel Co-Op
Axalta